KZR-616: Clinical Trials

1 trial of KZR-616, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow KZR-616: new trials by email Literature Review of KZR-616 trials Research Report on KZR-616

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis
KZR-616 - Lupus Nephritis, Systemic Lupus Erythematosus
Phase 1 / Phase 2CompletedKezar Life Sciences, Inc.692018-02-202025-11-18

Conditions studied

Lupus Erythematosus, Systemic (1)  ·  Lupus Nephritis (1)  ·  Nephritis (1)

Sponsors

Kezar Life Sciences, Inc. (1)

Countries

Australia (1)  ·  Colombia (1)  ·  Mexico (1)  ·  Peru (1)  ·  Poland (1)  ·  Russia (1)  ·  Ukraine (1)  ·  United States (1)

Results publications

PMID 37528520